AMITRIPTYLINE HYDROCHLORIDE | A217411 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.2973
per ea
Lowest NADAC/Unit
$0.0294
per ea
Brand NDCs
0
Generic NDCs
11
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571011001AMITRIPTYLINE HCL 150 MG TAB | $0.2973 | EA | Generic | — | 2026-06-17 |
| 16571010901AMITRIPTYLINE HCL 100 MG TAB | $0.1506 | EA | Generic | — | 2026-06-17 |
| 16571010801AMITRIPTYLINE HCL 75 MG TAB | $0.1112 | EA | Generic | — | 2026-06-17 |
| 16571010701AMITRIPTYLINE HCL 50 MG TAB | $0.0957 | EA | Generic | — | 2026-06-17 |
| 16571010710AMITRIPTYLINE HCL 50 MG TAB | $0.0957 | EA | Generic | — | 2026-06-17 |
| 00904741161AMITRIPTYLINE HCL 50 MG TAB | $0.0957 | EA | Generic | — | 2026-06-17 |
Showing 6 of 11 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.